Exagen Inc. (XGN)
NASDAQ: XGN · Real-Time Price · USD
6.59
-0.06 (-0.90%)
At close: Aug 6, 2026, 4:00 PM EDT
6.59
0.00 (0.00%)
Pre-market: Aug 7, 2026, 4:00 AM EDT
Exagen Market Cap
Exagen has a market cap or net worth of $159.21 million as of August 6, 2026. Its market cap has decreased by -18.42% in one year.
Market Cap
159.21M
Enterprise Value
162.28M
1-Year Change
-18.42%
Ranking
Category
Stock Price
$6.59
ChartMarket Cap Chart
Since September 19, 2019, Exagen's market cap has increased from $63.11M to $159.21M, an increase of 152.30%. That is a compound annual growth rate of 14.39%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 6, 2026 | 159.21M | 15.55% |
| Dec 31, 2025 | 137.79M | 90.55% |
| Dec 31, 2024 | 72.31M | 113.18% |
| Dec 29, 2023 | 33.92M | -13.39% |
| Dec 30, 2022 | 39.17M | -79.17% |
| Dec 31, 2021 | 187.99M | 12.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Sep 19, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Freenome | 1.23B |
| OPKO Health | 1.00B |
| Castle Biosciences | 922.60M |
| Fulgent Genetics | 507.93M |
| Myriad Genetics | 302.73M |
| Biodesix | 238.08M |
| Insight Molecular Diagnostics | 161.77M |
| Burning Rock Biotech | 94.50M |